USD 0.27
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 230.24 Thousand USD | -65.43% |
2022 | 578.49 Thousand USD | -63.59% |
2021 | 1.58 Million USD | 207.22% |
2020 | 517.17 Thousand USD | -52.69% |
2019 | 1.09 Million USD | 0.0% |
2011 | 2.67 Million USD | 649.38% |
2010 | 357.48 Thousand USD | -70.89% |
2009 | 1.22 Million USD | -89.75% |
2008 | 11.97 Million USD | 256.15% |
2007 | 3.36 Million USD | 36722.14% |
2006 | 9134.00 USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 16.16 Thousand USD | 101.04% |
2024 Q2 | 30.1 Thousand USD | 86.27% |
2023 Q4 | -1.55 Million USD | -5266.67% |
2023 Q3 | 30 Thousand USD | -98.17% |
2023 Q2 | 1.64 Million USD | 1950.0% |
2023 FY | 200 Thousand USD | -65.43% |
2023 Q1 | 80 Thousand USD | 152.03% |
2022 Q2 | 510.52 Thousand USD | 436.99% |
2022 Q1 | 95.07 Thousand USD | -60.91% |
2022 Q3 | 126.65 Thousand USD | -75.19% |
2022 Q4 | -153.77 Thousand USD | -221.4% |
2022 FY | 578.49 Thousand USD | -63.59% |
2021 Q3 | 518.86 Thousand USD | -16.69% |
2021 Q1 | 204.03 Thousand USD | 58.7% |
2021 FY | 1.58 Million USD | 207.22% |
2021 Q4 | 243.21 Thousand USD | -53.13% |
2021 Q2 | 622.77 Thousand USD | 205.24% |
2020 Q3 | 127.97 Thousand USD | -4.92% |
2020 Q2 | 134.59 Thousand USD | 3.28% |
2020 Q1 | 130.32 Thousand USD | 0.0% |
2020 FY | 517.17 Thousand USD | -52.69% |
2020 Q4 | 128.56 Thousand USD | 0.46% |
2019 FY | 1.09 Million USD | 0.0% |
2012 Q2 | 1.41 Million USD | 68.3% |
2012 Q3 | 1.23 Million USD | -12.27% |
2012 Q1 | 839.54 Thousand USD | 49.55% |
2011 Q3 | 949.16 Thousand USD | 32.63% |
2011 FY | 2.67 Million USD | 649.38% |
2011 Q4 | 561.39 Thousand USD | -40.85% |
2011 Q2 | 715.64 Thousand USD | 3836.85% |
2011 Q1 | 18.17 Thousand USD | 225.36% |
2010 Q1 | 49.6 Thousand USD | -66.93% |
2010 FY | 357.48 Thousand USD | -70.89% |
2010 Q2 | 13.37 Thousand USD | -73.05% |
2010 Q3 | 19.21 Thousand USD | 43.73% |
2010 Q4 | 5587.00 USD | -70.93% |
2009 Q2 | 209.26 Thousand USD | -19.33% |
2009 Q3 | 142.27 Thousand USD | -32.01% |
2009 Q4 | 149.99 Thousand USD | 5.43% |
2009 FY | 1.22 Million USD | -89.75% |
2009 Q1 | 259.38 Thousand USD | -33.72% |
2008 Q1 | 816.85 Thousand USD | -19.82% |
2008 Q4 | 391.34 Thousand USD | 6.32% |
2008 Q3 | 368.09 Thousand USD | -96.18% |
2008 Q2 | 9.64 Million USD | 1081.0% |
2008 FY | 11.97 Million USD | 256.15% |
2007 FY | 3.36 Million USD | 36722.14% |
2007 Q2 | 1.68 Million USD | 2.77% |
2007 Q3 | 250.82 Thousand USD | -85.09% |
2007 Q4 | 1.01 Million USD | 306.16% |
2007 Q1 | 1.63 Million USD | 5093.7% |
2006 Q3 | 11.9 Thousand USD | 0.0% |
2006 FY | 9134.00 USD | 0.0% |
2006 Q4 | 31.52 Thousand USD | 164.76% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
CVR Medical Corp. | - USD | -Infinity% |
BioElectronics Corporation | 740.67 Thousand USD | 68.915% |
IR-Med Inc. | 4.89 Million USD | 95.295% |
Polarean Imaging plc | 12.24 Million USD | 98.119% |
Medical Supply International USA, Inc. | 1.32 Million USD | 82.564% |
Avitar, Inc. | 3.56 Million USD | 93.55% |
AVITA Medical, Inc. | 80.77 Million USD | 99.715% |
Manhattan Scientifics, Inc. | 703 Thousand USD | 67.249% |
Össur hf. | 396.18 Million USD | 99.942% |
Zecotek Photonics Inc. | 3.46 Million USD | 93.348% |
QHSLab, Inc. | 961.65 Thousand USD | 76.058% |
Wellstar International, Inc. | 1.79 Million USD | 87.171% |
Össur hf. | 396.18 Million USD | 99.942% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 21.77 Million USD | 98.943% |
Escalon Medical Corp. | 5.25 Million USD | 95.615% |
Aurora Spine Corporation | 8.65 Million USD | 97.341% |
BrainsWay Ltd. | 28.01 Million USD | 99.178% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | 9.56 Million USD | 97.593% |
Hamilton Thorne Ltd. | 33.57 Million USD | 99.314% |
Vivos Inc. | 2.78 Million USD | 91.739% |
MicroPort Scientific Corporation | 1.04 Billion USD | 99.978% |
Kelyniam Global, Inc. | 2.27 Million USD | 89.881% |
REMSleep Holdings, Inc. | 1.01 Million USD | 77.314% |
CYduct Diagnostics, Inc. | 435.5 Thousand USD | 47.132% |
Nanomix Corporation | 8.36 Million USD | 97.248% |
Theraclion SA | 7.43 Million USD | 96.905% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 1.29 Million USD | 82.215% |
Positron Corporation | 1 Million USD | 77.142% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 3.11 Million USD | 92.598% |
Lombard Medical, Inc. | 30.29 Million USD | 99.24% |
ALR Technologies Inc. | 6.33 Million USD | 96.366% |
Stratec SE | 46.32 Million USD | 99.503% |
Vycor Medical, Inc. | 1.27 Million USD | 81.948% |
Heart Tronics, Inc. | 14.46 Million USD | 98.408% |
Nu-Med Plus, Inc. | 120.52 Thousand USD | -91.03% |
Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -11.541% |
SANUWAVE Health, Inc. | 14.15 Million USD | 98.373% |
VMS Rehab Systems, Inc. | 63.63 USD | -361743.47% |
Guided Therapeutics, Inc. | 3.49 Million USD | 93.409% |
Ingen Technologies, Inc. | 1.88 Million USD | 87.768% |
Odyssey Group International, Inc. | -14.26 Million USD | 101.614% |
United American Healthcare Corporation | 59 Thousand USD | -290.239% |
ECGI Holdings, Inc. | 407.48 Thousand USD | 43.497% |
Capital Group Holdings, Inc. | 634.68 Thousand USD | 63.724% |
ADM Tronics Unlimited, Inc. | 1.69 Million USD | 86.421% |
Urologix, Inc. | 10.09 Million USD | 97.719% |
Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 81.775% |
Nexeon MedSystems Inc. | 5.94 Million USD | 96.129% |
SS Innovations International, Inc. | 21.38 Million USD | 98.923% |
Smith & Nephew plc | 3.46 Billion USD | 99.993% |
NIOX Group Plc | 22.27 Million USD | 98.966% |
Fuse Medical, Inc. | 10.35 Million USD | 97.775% |
Broncus Holding Corporation | 38.15 Million USD | 99.397% |
Brain Scientific Inc. | 9.66 Million USD | 97.617% |
Pressure BioSciences, Inc. | 10.3 Million USD | 97.765% |
Health Logic Interactive Inc. | 60.69 Thousand USD | -279.322% |